Have posted my experiences on the other LDN thread. Basically I managed 6 weeks at 2.0 titrated up from 0.5. When I moved up to 2.5, I had severe gastric symptoms. Stopped for 2 weeks then restarted at 2.0 but within 2 hours, I had severe gastric upset, insomnia.
Feeling frustrated because it was certainly helping cognitive function which has deteriorated again. Am trying to get it prescribed sublingually. Fingers crossed.
Does anyone know when we might expect results from the research planned at the clinicians’ summit? Do we know how the research will take place?